Rare and Undiagnosed Diseases Group
Rare and Undiagnosed Diseases Group
Rare and Undiagnosed Diseases Group
Uğur ÖZBEK
Yavuz OKTAY
Kasım DİRİL
Duygu SAĞ
Serap ERKEK
Researchers / Senior Researchers
Clinical Scientists
İBG - RUDiP

Disease Epigenetics

serap erkek lab

Principal Investigator: Assoc. Prof. Serap ERKEK

Epigenetic dysregulation underlies a wide spectrum of disorders, from common cancers to rare genetic diseases. Our laboratory deciphers gene‑regulatory mechanisms directly at the chromatin level by integrating multi‑omics profiling with detailed biochemical and functional assays. We are especially interested in pathogenic mutations in genes encoding subunits of the MLL/COMPASS histone‑methyltransferase complexes and on how these lesions rewire regulatory networks. By characterizing the epigenetic changes associated with these mutations and identifying actionable molecular vulnerabilities, we aim to stratify patients more precisely and contribute to the development of mechanism-based therapies.

serap erkek

Research Areas 

1. Understanding and manipulating epigenome in relation to chromatin modifier mutations

Multi-omics profiling (ChIP-seq, CUT&RUN-seq, RNA-seq, DNAmetylation-seq), functional assays

2. Deciphering transcriptional regulatory networks

ATAC-seq ve H3K27ac ChIP-seq, transcription factor mofif analysis, transcription factor prioritization

3. Understanding individual domain functions of chromatin modifiers

Creation of constructs expressing chromatin modifier domains, Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins (RIME), identification of protein-protein interactions, prioritization using AlphaFold.

Publications

Dayanc B.* , Eris S.*, Gulfirat N.E., Ozden-Yilmaz G., Cakiroglu E., Coskun Deniz O.S., Karakülah G., Erkek-Ozhan S., Senturk S. Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer. Cell Death Dis. 16(1):414 (2025). *Equal first author contribution.

Akman B., Bursalı A., Gürses M., Suner A., Karakülah G., Mungan U., Yörükoğlu K., Erkek-Ozhan         S. Nucleocytoplasmic β-catenin expression contributes to neuroendocrine differentiation in muscle           invasive bladder cancer. Cancer Sci. 115(9):2985-2997 (2024).

Ozgun G., Yaras T.,  Akman B., Özden-Yılmaz G., Landman N.,  Karakülah G.,  van Lohuizen M., Senturk  S., Erkek-Ozhan, S. Retinoids and EZH2 inhibitors cooperate to orchestrate cytotoxic effects on bladder cancer cells. Cancer Gene Therapy. 31(4):537-551 (2024).

Ozden-Yılmaz G., Savas B., Bursalı  A., Eray A., Arıbaş A., Senturk  S., Karaca E., Karakülah G., Erkek-Ozhan, S. Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines. Cells. 12(6):836 (2023).

Guneri-Sozeri, P.Y*., Ozden-Yilmaz G.*, Kisim A., Cakiroglu E., Eray A., Uzuner H., Karakülah G.,         Pesen   Okvur D., Senturk S., Erkek-Ozhan, S. FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer. Commun Biol. 6(1):199 (2023). *Equal first author contribution.

Projects

TÜBİTAK 2519 COST Action Support Program, Determination of the role of FLI1 transcription factor in tumor immunity and immunotherapy responses in bladder cancer, Ongoing

TÜBİTAK 2519 COST Action Support Program, Identification of MECOM as a biomarker in pancreatic cancer and determination of epigenetic inhibitor response in MECOM-expressing pancreatic cancer cells, Ongoing

TÜBİTAK 1001, Association of enzymatic domain-dependent functions of KDM6A protein with NF-κB signaling pathway and macrophage function in bladder cancer, Ongoing

EMBO Installation Grant, Identification of epigenetic mechanisms causing bladder cancer, Ongoing

TÜSEB Group B, Investigation of the effects of mutations occurring in the FYR module of the KMT2D gene associated with Kabuki Syndrome on protein interactions and chromatin organization, Ongoing

TÜBİTAK 2247-A National Leading Researchers Program, The role of β-catenin in neuroendocrine and neuroendocrine-like bladder tumors, Completed

TÜBİTAK 3501, Identification of transcriptional regulatory networks characterizing invasive and non-invasive bladder cancer cell lines, Completed

Staff

Active Members

Ezgi Boyvatlı
Ahmet Can Tülü
Burcu Akman

Former Members

Gizem Özgün (Doctoral Student)
Ezgi Boyvatlı (Master's Student)
Perihan Yağmur Güneri (Master's Student)
Aleyna Eray (Master's Student)